Breast Tumor Board - PNH 2025 - 6/20/2025

Friday, June 20, 2025, 12:30 PM - 1:30 PM, Other, Newnan, GA


AMA PRA Category 1 Credits™ (1.00 hours), ANCC Contact Hour(s) (1.00 hours), ASWB CE Credit (1.00 hours), CDR CPEU (1.00 hours), IPCE Credit (1.00 hours), Non-Physician Attendance (1.00 hours), Social Work - General (1.00 hours)

The interprofessional team meets to review breast cancer patients) and develop treatment plans with discussion and input from all members of the care team to optimize and coordinate multidisciplinary care, practice evidence-based care, adhere to national guidelines for care, and coordinate clinical trials if appropriate. The activity also serves as an educational forum for review of new treatments, new procedures, or recently FDA approved drugs. It also offers the opportunity for the team to discuss and manage particularly complex, rare or unusual diagnostic or treatment issues for which existing guidelines are not always clear. Lecture-type Activity This series presents the latest practice guidelines and late-breaking research in the subspecialties of medicine. Lectures focus on the prevention of disease, management and treatment of patients with a basic understanding of disease process and updates on novel therapies.

1. Demonstrate a collaborative approach to care for patients through communications among all members of the breast cancer team.
2. Examine all possible treatment options to ensure patient's safety when managing treatment plan.
3. Discuss efficacy of comprehensive treatment plans with oncology team.
4. Design a specific treatment plan using the latest guidelines.
5. Review recent cases and identify what could be improved for optimal patient outcome.
6. State the indications for and identify patients eligible for clinical trials, genetic testing, and rehab/supportive services.
7. Improve communication between multi-specialty clinicians and professionals
8. Discuss all components necessary to determine plan of care (i.e. pathology, imaging, psycho-social issues, socioeconomic barriers, ancillary services, operative approach, systemic therapy and radiation) with anticipation of adjuvant care for survivorship and surveillance

In support of improving patient care, Piedmont Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

In addition to AMA PRA Category 1 Credit^TM for physicians, ANCC credit for nurses, and ACPE credit for pharmacists, Piedmont Healthcare also offers AAPA Category 1 Credit for PAs, APA credit for psychologists, ASWB ACE credit for social work, BOC credit for athletic trainers, CPEU CDR credit for dietitians, and IPCE credit. 

Cancellation Policy

Piedmont Healthcare reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
Piedmont Healthcare is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact Continuing Education at [email protected].

Piedmont Healthcare adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Piedmont Healthcare adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
6/20/2025 12:30:00 PM	Breast Tumor Board - PNH 2025 - 6/20/2025 6/20/2025 12:30:00 PM 6/20/2025 1:30:00 PM 15 Other False MM/DD/YYYY	Breast Tumor Board - PNH 2025 - 6/20/2025 The interprofessional team meets to review breast cancer patients) and develop treatment plans with discussion and input from all members of the care team to optimize and coordinate multidisciplinary care, practice evidence-based care, adhere to national guidelines for care, and coordinate clinical trials if appropriate. The activity also serves as an educational forum for review of new treatments, new procedures, or recently FDA approved drugs. It also offers the opportunity for the team to discuss and manage particularly complex, rare or unusual diagnostic or treatment issues for which existing guidelines are not always clear. Lecture-type Activity This series presents the latest practice guidelines and late-breaking research in the subspecialties of medicine. Lectures focus on the prevention of disease, management and treatment of patients with a basic understanding of disease process and updates on novel therapies. Location: Other